Emage Innovation Aesthetic Solutions

Emage Medical is a US-based medical aesthetic device manufacturer specializing in skin rejuvenation, microneedling, and imaging technologies. The company develops FDA-cleared aesthetic systems including microneedling platforms (CytoPen NG, CytoPen S2, StemFacial), radiofrequency microneedling (Cyto-RF), hydradermabrasion (CytoPeel), and advanced skin imaging systems (Image Pro 3D Sunlite). Product offerings also include complementary skincare formulations (CytoSolutions, CytoSerum) designed to enhance treatment outcomes. Emage targets aesthetic practices, medspa operators, and boutique clinics nationwide, offering flexible financing (rental and purchase options starting at $74–$554 monthly). The company emphasizes affordability, comprehensive support including unlimited 1:1 training during warranty periods, and industry-leading 3-year warranties with 5-year extended options. All core devices carry FDA clearance. Manufacturing and customer support are US-based. The company positions itself on engineering excellence (smart algorithms, self-sanitizing equipment, real-time photo alignment), expertise (nearly a century of combined team experience in aesthetics and marketing), and customer success partnerships rather than transactional sales.